Navigation Links
LCA-Vision Adopts Stockholder Rights Plan
Date:11/24/2008

CINCINNATI, Nov. 24 /PRNewswire-FirstCall/ -- LCA-Vision Inc. (Nasdaq: LCAV) ("LCA-Vision" or the "Company"), a leading provider of laser vision correction services under the LasikPlus(R) brand, today announced that its Board of Directors has adopted a stockholder rights plan, and in connection with the rights plan has declared a dividend distribution of one preferred stock purchase right on each outstanding share of LCA-Vision common stock.

Under a Rights Agreement entered into on November 24, 2008 in connection with the adoption of the rights plan, each right will entitle stockholders to buy one one-hundredth newly-issued share of the Company's Series A Junior Participating Preferred Stock at a purchase price of $100.00. The rights initially will trade only with the shares of LCA-Vision common stock to which they are attached, and no separate rights certificates will be issued.

The rights will become exercisable only if a person or group acquires or obtains the right to acquire ownership of 20% or more of LCA-Vision common stock, commences a tender or exchange offer for 20% or more of the common stock, or is declared an "Adverse Person" by the Board of Directors of the Company. The Company will be entitled to redeem the rights at one-tenth of one cent per right at any time before the tenth business day following the date a 20% position has been acquired or a person has been declared an "Adverse Person."

If LCA-Vision is acquired in a merger or other business combination transaction, each right will entitle its holder to purchase, at the right's then-current exercise price, a number of the acquiring company's common shares having a market value at that time of twice the right's exercise price. The rights also provide a similar right for holders (other than an Acquiring Person or Adverse Person as defined in the Rights Agreement) to purchase common shares of LCA-Vision having a market value at that time of twice the right's exercise price under certain circumstances where a person or group has acquired a 20% block of LCA-Vision common stock or been declared an "Adverse Person" by a majority of LCA-Vision's outside directors.

"The rights plan does not prevent a takeover, but is intended to ensure that LCA-Vision's stockholders receive equal treatment in the event of any proposed takeover, and to guard against tactics that could impair the Board's ability to represent stockholders' interests fully. We seek to enable all LCA-Vision stockholders to realize the maximum possible long-term value of their investment in the Company," said Steve Straus, LCA-Vision's Chief Executive Officer. The stockholder rights plan adopted by LCA-Vision is similar to rights plans adopted by many other publicly traded companies.

The distribution of rights will be made on November 24, 2008 to stockholders of record on that date. The rights will expire 10 years later on November 23, 2018. In addition, the rights will terminate one year from the date of their issuance, on November 23, 2009, unless adoption of the rights plan has been ratified by LCA-Vision stockholders prior to that time. The rights distribution is not taxable to stockholders.

Additional information regarding the rights plan and the rights are or will be contained in a Current Report on Form 8-K and in a Registration Statement on Form 8-A that the Company has filed or will be filing with the Securities and Exchange Commission (the "SEC"). These filings will be available on the SEC's web site at www.sec.gov. In addition, the Company will make available to its stockholders upon request a "Summary of the Rights" that will describe the material terms of the rights plan.

About LCA-Vision Inc./LasikPlus(R)

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus(R) brand, operates 77 LasikPlus(R) fixed-site laser vision correction centers in 33 states and 59 markets in the United States and a joint venture in Canada. Additional company information is available at www.lca-vision.com and www.lasikplus.com.

                         Earning Trust Every Moment.

                        Transforming Lives Every Day.

    For Additional Information

    Company Contact:             Investor Relations Contact:
    Barb Kise                    Jody Cain
    LCA-Vision, Inc.             Lippert/Heilshorn & Associates
    513-792-9292                 310-691-7100

'/>"/>
SOURCE LCA-Vision Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company
2. LCA-Vision to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
3. LCA-Vision Reports Third Quarter 2008 Financial Results
4. LCA-Vision Named Provider for New Insured Lasik Product
5. LCA-Vision Announces Upcoming Investment Community Events
6. LCA-Vision Provides Business Update and Market Review
7. LCA-Vision Announces CFO Change
8. LCA-Vision Announces Upcoming Investment Community Events
9. LCA-Vision Conducts 2008 Annual Stockholder Meeting
10. LCA-Vision to Present at the Bank of America 2008 Health Care Conference
11. LCA-Vision Announces the Opening of its 76th LasikPlus(R) Vision Center in Woodbridge, New Jersey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... ... July 24, 2017 , ... Peruvian Ayahuasca retreat, ... be awarded annually to and divided between two full-time university students enrolled in ... Amazonian plant medicine. To apply for the scholarship, students are asked to submit ...
(Date:7/24/2017)... ... 24, 2017 , ... The Topricin Companies, formerly Topical Biomedics, ... revolutionary, natural, after-burn skin care product, Topricin After Burn Cream. , ... skin conditions, including cancer. In the short term, overexposure to sun, wind ...
(Date:7/24/2017)... Switzerland (PRWEB) , ... July 24, 2017 , ... Anyone ... to weigh a watermelon, nor would a pharmacist using that same scale to dispense ... risk someone’s health. , These illustrations show why it is important to have ...
(Date:7/24/2017)... ... 2017 , ... Paul Vitenas, MD, FACS is excited to report that he ... attend Allergan’s recent meeting with their Plastics Advisory Board. As one of the top ... bringing a newly defined structure to the aesthetics market. Dr. Vitenas , along ...
(Date:7/24/2017)... ... ... Summer storms are inevitable as weather temperatures in Philadelphia climb. These ... tree damage requiring emergency tree service. Giroud Tree and Lawn provides ... hazardous tree removal. , “A summer storm is like a bully on ...
Breaking Medicine News(10 mins):
(Date:7/5/2017)... 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... ), a clinical-stage pharmaceutical company focused on the development of ... approval from the Israel Securities Authority to dual-list its common ... stock will commence trading on the TASE on July 12, ... capitalization of the Company, it is expected that Oramed will ...
(Date:7/5/2017)...   BioLife Solutions , Inc. (NASDAQ: ... proprietary clinical grade cell and tissue hypothermic storage ... announced that it has reached an agreement with WAVI ... to modify its existing credit facility effective June 30, ... agreed to exchange its existing $4.25 million credit facility, ...
(Date:6/30/2017)... ROCKVILLE, Md. , June 30, 2017 ... that since the start of May, at least ten ... financings include private investments, public offerings and a loan ... $3.3 million to almost $80 million.  Kalorama Information provides ... customers of its Diagnostics Knowledge Center. ...
Breaking Medicine Technology: